Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1988 1
1989 1
1991 3
1993 1
1994 1
1995 2
1996 1
1997 2
1998 1
1999 2
2000 1
2004 1
2005 1
2006 1
2007 2
2009 1
2010 3
2011 6
2012 4
2013 2
2014 4
2015 4
2016 1
2017 4
2018 3
2019 2
2020 2
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

49 results

Results by year

Filters applied: . Clear all
Page 1
Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial.
Gnant M, Pfeiler G, Dubsky PC, Hubalek M, Greil R, Jakesz R, Wette V, Balic M, Haslbauer F, Melbinger E, Bjelic-Radisic V, Artner-Matuschek S, Fitzal F, Marth C, Sevelda P, Mlineritsch B, Steger GG, Manfreda D, Exner R, Egle D, Bergh J, Kainberger F, Talbot S, Warner D, Fesl C, Singer CF; Austrian Breast and Colorectal Cancer Study Group. Gnant M, et al. Lancet. 2015 Aug 1;386(9992):433-43. doi: 10.1016/S0140-6736(15)60995-3. Epub 2015 May 31. Lancet. 2015. PMID: 26040499 Clinical Trial.
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer.
Sarhan D, Leijonhufvud C, Murray S, Witt K, Seitz C, Wallerius M, Xie H, Ullén A, Harmenberg U, Lidbrink E, Rolny C, Andersson J, Lundqvist A. Sarhan D, et al. Among authors: lidbrink e. Oncoimmunology. 2017 Jun 14;6(8):e1338238. doi: 10.1080/2162402X.2017.1338238. eCollection 2017. Oncoimmunology. 2017. PMID: 28920001 Free PMC article.
Dietary habits and prognostic factors in breast cancer.
Holm LE, Callmer E, Hjalmar ML, Lidbrink E, Nilsson B, Skoog L. Holm LE, et al. Among authors: lidbrink e. J Natl Cancer Inst. 1989 Aug 16;81(16):1218-23. doi: 10.1093/jnci/81.16.1218. J Natl Cancer Inst. 1989. PMID: 2547078
Angiogenic factors in relation to clinical effect in a phase II trial of weekly paclitaxel.
Linderholm BK, Lidbrink E, Tallroth E, Einbeigi Z, Svensson H, von Wachenfeldt A, Norberg B, Carlsson L, Olsson ME, Bergh J, Wilking N, Hatschek T. Linderholm BK, et al. Among authors: lidbrink e. Breast. 2013 Dec;22(6):1142-7. doi: 10.1016/j.breast.2013.07.041. Epub 2013 Aug 20. Breast. 2013. PMID: 23968864 Free article. Clinical Trial.
Efficacy and safety of ultra-low dose 0.005% estriol vaginal gel for the treatment of vulvovaginal atrophy in postmenopausal women with early breast cancer treated with nonsteroidal aromatase inhibitors: a phase II, randomized, double-blind, placebo-controlled trial.
Hirschberg AL, Sánchez-Rovira P, Presa-Lorite J, Campos-Delgado M, Gil-Gil M, Lidbrink E, Suárez-Almarza J, Nieto-Magro C. Hirschberg AL, et al. Among authors: lidbrink e. Menopause. 2020 May;27(5):526-534. doi: 10.1097/GME.0000000000001497. Menopause. 2020. PMID: 32049923 Free PMC article. Clinical Trial.
49 results